What's new

Human medicines European public assessment report (EPAR): Armisarte (previously Pemetrexed Actavis), pemetrexed, Date of authorisation: 18/01/2016, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR): Armisarte (previously Pemetrexed Actavis), pemetrexed, Date of authorisation: 18/01/2016, Revision: 15, Status: Authorised

Feb 11, 2025 - 16:10
 0
Human medicines European public assessment report (EPAR): Armisarte (previously Pemetrexed Actavis), pemetrexed, Date of authorisation: 18/01/2016, Revision: 15, Status: Authorised
Human medicines European public assessment report (EPAR): Armisarte (previously Pemetrexed Actavis), pemetrexed, Date of authorisation: 18/01/2016, Revision: 15, Status: Authorised
Read More

Tags:

Previous Article

Passenger Uses A Resting Traveler As A Chair At San Francisco Airport – Video Sh...

Next Article

Supporting innovation

Related Posts

Human medicines European public assessment report (EPAR): Relvar Ellipta, fluticasone furoate,vilanterol, Date of authorisation: 13/11/2013, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 24, 2025  0

Human medicines European public assessment report (EPAR): Litfulo, ritlecitinib, Date of authorisation: 15/09/2023, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 27, 2025  0

EMEA-002640-PIP01-19-M01

EMEA-002640-PIP01-19-M01

Feb 14, 2025  0